Moreover, VEGF-C is overexpressed in several cancer types (Su et al., 2007) including prostatic carcinoma (Tsurusaki et al., 1999; Zeng et al., 2004; Jennbacken et al., 2005; Yang et al., 2006; Yang et al., 2014). This evidence concerns the gene VEGFC and cancer.